• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    ProPhase Labs Launches BE-Smart Sale, Advances Crown Initiative

    GLOBENEWSWIRE

    Prophase Labs Hosts Live Investor Webinar On February 3

    GLOBENEWSWIRE

    ProPhase Labs Provides Crown Medical Collections Update

    GLOBENEWSWIRE

    Prophase Labs Uplists From Pink Sheets To OTC Market

    GLOBENEWSWIRE

    ProPhase Labs Updates on Debt Conversions and Capital Structure

    GLOBENEWSWIRE

    Prophase Labs Enters Non-Binding LOI For Reverse Merger

    GLOBENEWSWIRE

    Prophase Labs Hosts Live Investor Webinar On December 1

    GLOBENEWSWIRE

    Prophase Labs To Report Q3 2025 Results, Host Virtual Conference

    GLOBENEWSWIRE

    Prophase Labs To Unveil Q3 2025 Financial Results On Nov 19

    GLOBENEWSWIRE

    Prophase Labs Urges Shareholders To Vote On Proxy Proposals

    GLOBENEWSWIRE

    Prophase Labs Publishes Be-Smart Esophageal Cancer Study

    GLOBENEWSWIRE

    Prophase Labs Partners With Redchip For Investor Relations Effort

    GLOBENEWSWIRE

    Prophase Labs To Present At The 2025 Thinkequity Conference

    GLOBENEWSWIRE

    Prophase Labs Validates Be-Smart Esophageal Cancer Test

    GLOBENEWSWIRE

    Prophase Labs Completes Key Step In $50m Crown Medical

    GLOBENEWSWIRE

    Prophase Continues Its Exploration Of A Crypto Treasury Strategy

    GLOBENEWSWIRE

    ProPhase Holders 75%+ Approve All Proposals at Sept 9 Meeting

    GLOBENEWSWIRE

    ProPhase Labs Files Proxy, Sets New Meeting Date

    GLOBENEWSWIRE

    ProPhase Labs Reports Financial Results for H1 2025

    GLOBENEWSWIRE

    ProPhase Labs Gets USPTO Patent for Esophageal Adenocarcinoma

    GLOBENEWSWIRE

    ProPhase Labs Presents Q2 2025 Financial Results on Aug 13

    GLOBENEWSWIRE

    ProPhase Labs Calls Shareholder Meeting, Files Proxy Statement

    GLOBENEWSWIRE

    ProPhase Labs Closes $3M Secured Convertible Notes Financing

    GLOBENEWSWIRE

    ProPhase Labs Explores Reverse Merger, Approves Crypto Initiative

    GLOBENEWSWIRE

    ProPhase Labs Study Shows BE-Smart Test Detects Esophageal Cancer

    GLOBENEWSWIRE

    ProPhase Labs Forms Clinical Science Advisory Board for BE-SmartT

    GLOBENEWSWIRE

    ProPhase Labs Announces Q1 2025 Financial Results

    GLOBENEWSWIRE

    ProPhase Labs to Present Q1 2025 Financial Results on May 20

    GLOBENEWSWIRE

    ProPhase Labs Announces 2024 Year-End Financial Results

    GLOBENEWSWIRE

    ProPhase Labs to Present 2024 Financial Results on March 31, 2025

    GLOBENEWSWIRE

    ProPhase Labs to Present at Investor Summit Virtual on March 11

    GLOBENEWSWIRE

    ProPhase Labs Explores DTC Media Infrastructure for Telehealth Rx

    GLOBENEWSWIRE

    ProPhase Targets $50M In Cash Recovery From COVID-19 Receivables

    GLOBENEWSWIRE

    ProPhase Labs Names Stuart Hollenshead As New COO

    GLOBENEWSWIRE

    ProPhase Labs Closes $23.6M Sale Of Pharmaloz Manufacturing

    GLOBENEWSWIRE

    ProPhase Labs Secures Private Equity, Nears Lozenge Deal

    GLOBENEWSWIRE

    ProPhase Labs Reports Financial Results for Q3 2024

    GLOBENEWSWIRE

    ProPhase Labs Announces Closing of Public Offering of Common Stock

    GLOBENEWSWIRE

    ProPhase Labs to Present Q3 2024 Financials on Nov 13

    GLOBENEWSWIRE

    ProPhase Labs Announces Pricing of Public Offering of Common Stock

    GLOBENEWSWIRE

    ProPhase Labs Announces Proposed Public Offering of Common Stock

    GLOBENEWSWIRE

    ProPhase Lab Announces Pricing of Public Offering of Common Stock

    GLOBENEWSWIRE

    ProPhase Labs Launches DNA Complete® for Direct-to-Consumer Testing

    GLOBENEWSWIRE

    ProPhase Labs to Present at the 2024 ThinkEquity Conference

    GLOBENEWSWIRE

    ProPhase Labs Updates On Strategic Initiatives And Liquidity Events

    GLOBENEWSWIRE

    ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event

    GLOBENEWSWIRE

    ProPhase Labs Announces Q2 2024 Financial Results Ending June 30, 2024

    GLOBENEWSWIRE

    ProPhase Labs Partners With Forward Healthcare For BE-Smart Test

    GLOBENEWSWIRE

    PROPHASE LABS INC. TO PRESENT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 14

    GLOBENEWSWIRE

    ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress

    GLOBENEWSWIRE

    ProPhase Labs Q1 2024 Results, Progress On Strategic Initiatives

    GLOBENEWSWIRE

    ProPhase Labs Q1 2024 Financials, Progress On Strategic Initiatives

    GLOBENEWSWIRE

    PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9

    GLOBENEWSWIRE

    ProPhase Labs To Present At Planet MicroCap Showcase: VEGAS 2024 On May 1

    GLOBENEWSWIRE

    ProPhase Labs Unveils Project ZenQ-AI

    GLOBENEWSWIRE

    ProPhase Labs Launches BE-Smart Test to Transform Esophageal Cancer Detection

    GLOBENEWSWIRE

    ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    GLOBENEWSWIRE

    ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023

    GLOBENEWSWIRE

    Prophase Labs To Present 2023 Year End Financial Results On March 15, 2024

    GLOBENEWSWIRE

    ProPhase Announces Progress in BE-Smart Esophageal Cancer Test Development

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.